Tag: phase 2 clinical trial

January 8, 2020

Catabasis to Evaluate Muscular Dystrophy Treatment

Catabasis has entered into a partnership for a Phase 2 trial of a novel NF-kB inhibitor that treats a form...
January 7, 2020

Cytokinetics Starts Phase 2 Clinical Trial for Cardiomyopathy Treatment

The company said its myosin inhibitor will be evaluated to optimize its dosing schedule to a therapeutic window for patients...
December 11, 2019

BioXcel Therapeutics to Expand BXCL701 Study

The company has announced it will advance its evaluation of BXCL701 into multiple advanced solid tumors in its Phase 2...
December 9, 2019

Mustang Bio Announces Additional Clinical Data on MB-107

The company announced that updated Phase 1/2 clinical data for MB-107 was presented at the 61st American Society of Hematology...
December 3, 2019

Cara Therapeutics Tumbles on Phase 2 Oral KORSUVA Results

Cara Therapeutics said Oral KORSUVA met its primary endpoint in the Phase 2 trial, but didn't meet its secondary endpoints.
December 2, 2019

Rafael Pharmaceuticals Expands Phase 2 CPI-613 Trial

The company has announced it will begin enrolling patients in Boston while the trial is currently underway in New York...
November 27, 2019

Verrica Pharmaceuticals Dips on FDA IND Acceptance

Verrica Pharmaceuticals' treatment could become the first one given the seal of approval by the FDA to treat molluscum contagiosum.